High expression of MTF1 also showed good OS for the ovarian cancer patients treated with multiple chemotherapy agents, including gemcitabine, paclitaxel, platin and topotecan (Supplementary Figure S5B). This evidence concerns the gene MTF1 and ovarian carcinoma.